Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly Forteo "Approvable": Indications, Manufacturing Issues To Be Resolved

Oct 08 2001

• By The Pink Sheet

Related Content

Lilly Post-Prozac Steps Include Charge Related To Ceclor Manufacturing

Oct 08 2001

Lilly Forteo Osteoporosis Indication Approval Recommended With Restrictions

Jul 30 2001

Lilly Zyprexa IM "Approvable"; GMP Consultants Hired In Wake Of Inspections

Apr 16 2001

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window